Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.0005 USD
Change Today 0.00 / 0.00%
Volume 0.0
CURXQ On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 05/21/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael R. Miller

Director, Chairperson of Audit Committee and Member of Compensation Committee, Curaxis Pharmaceutical Corporation
AgeTotal Calculated CompensationThis person is connected to 34 board members in 2 different organizations across 1 different industries.

See Board Relationships
64--

Background*

Mr. Michael R. Miller has been the Chief Financial Officer of the Delaware Art Museum since 2007. Mr. Miller served as Senior Vice President and Chief Financial Officer of DuPont Merck Pharmaceutical Company(alternately DuPont Pharmaceuticals) from February 1995 to June 1999. He worked a combined 26 years at E.I. DuPont de Nemours & Company until June 1999. He served at E.I. DuPont de Nemours, where, over the course of his tenure, he held numerous finance staff and management ...

Read Full Background

Corporate Headquarters*

1004 Chagford Way
Raleigh, North Carolina 27614

United States

Phone: 888-919-2873
Fax: --

Board Members Memberships*

2000-N/A
Former Director
2008-Present
Director
2011-Present
Director, Chairperson of Audit Committee and Member of Compensation Committee

Education*

BS 1973
Indiana University, Bloomington

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CURXQ:US $0.00 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CURAXIS PHARMACEUTICAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.